Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $8.63 Consensus Target Price from Analysts

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has been given an average rating of "Buy" by the six brokerages that are presently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $8.63.

Separately, Oppenheimer decreased their price objective on Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating for the company in a research report on Tuesday, April 22nd.

Bioceres Crop Solutions Stock Performance

Bioceres Crop Solutions stock traded up $0.45 during mid-day trading on Friday, reaching $4.83. 208,085 shares of the company were exchanged, compared to its average volume of 176,237. Bioceres Crop Solutions has a twelve month low of $3.51 and a twelve month high of $11.78. The firm's 50-day simple moving average is $4.52 and its two-hundred day simple moving average is $5.26. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.96 and a current ratio of 1.33. The firm has a market cap of $302.89 million, a PE ratio of 241.62 and a beta of 0.44.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) earnings per share for the quarter, topping analysts' consensus estimates of ($0.10) by $0.08. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.58%. The company had revenue of $59.60 million during the quarter, compared to analysts' expectations of $61.80 million. Equities analysts predict that Bioceres Crop Solutions will post -0.05 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of large investors have recently modified their holdings of BIOX. Fourth Sail Capital LP raised its stake in shares of Bioceres Crop Solutions by 16.6% during the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company's stock worth $22,490,000 after buying an additional 527,859 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Bioceres Crop Solutions by 17.0% during the 4th quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company's stock worth $640,000 after buying an additional 15,328 shares in the last quarter. Ballast Asset Management LP raised its stake in shares of Bioceres Crop Solutions by 23.5% during the 4th quarter. Ballast Asset Management LP now owns 431,887 shares of the company's stock worth $2,620,000 after buying an additional 82,187 shares in the last quarter. Jump Financial LLC purchased a new position in Bioceres Crop Solutions in the 4th quarter valued at approximately $72,000. Finally, Stifel Financial Corp raised its holdings in Bioceres Crop Solutions by 51.9% during the fourth quarter. Stifel Financial Corp now owns 61,958 shares of the company's stock worth $377,000 after purchasing an additional 21,168 shares during the last quarter. 17.68% of the stock is owned by hedge funds and other institutional investors.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.